Comparisons of levodopa plasma concentration in continuous LCIG infusion and neurological findings
-
- Yabe Hayato
- Department of Neurology, Saiseikai Matsuyama Hospital
-
- Ootsubo Haruki
- Department of Neurology and Clinical Pharmacology, Ehime University School of Medicine
-
- Kubo Madoka
- Department of Neurology and Clinical Pharmacology, Ehime University School of Medicine
-
- Miyaue Noriyuki
- Department of Neurology, Saiseikai Matsuyama Hospital
-
- Tada Satoshi
- Department of Neurology and Clinical Pharmacology, Ehime University School of Medicine
-
- Ando Rina
- Department of Neurology and Clinical Pharmacology, Ehime University School of Medicine
-
- Nagai Masahiro
- Department of Neurology and Clinical Pharmacology, Ehime University School of Medicine
-
- Nomoto Masahiro
- Department of Neurology and Clinical Pharmacology, Ehime University School of Medicine
Bibliographic Information
- Other Title
-
- L–ドパ持続経腸療法における血中濃度の検討―効果と課題について
Search this article
Description
<p>Introduction :</p><p>Levodopa carbidopa intestinal gel (LCIG) was approved for advanced Parkinson's disease (PD).</p><p>We performed LCIG therapy in patients with advanced PD.</p><p>The effect and problem including the plasma levodopa level in continues LCIG infusion were studied.</p><p></p><p>Method :</p><p>Six PD patients treated with LCIG were included in this study. Pharmacokinetics, efficacy and adverse events were assessed.</p><p></p><p>Results :</p><p>Compared with baseline, LCIG decreased off time. The degree of fluctuation of levodopa plasma concentrations were small while continues LCIG infusion.</p><p>In spite of the constant plasma levodopa, one of the 6 cases presented motor fluctuations.</p><p>Intersubject variability of levodopa plasma concentrations were present. And the plasma levodopa level of the same patient fluctuated among the days.</p><p>Therefore, there was no strict correlation between LCIG dosing rate and plasma concentration of levodopa, when compared with intravenous levodopa infusion.</p><p>The dosing rate of levodopa was adjusted according to the plasma levodopa concentration in one case.</p><p></p><p>Conclusion :</p><p>The monitoring of the levodopa plasma cncentrations is useful for determination of dosing rate.</p>
Journal
-
- Neurological Therapeutics
-
Neurological Therapeutics 36 (2), 91-95, 2019
Japanese Society of Neurological Therapeutics
- Tweet
Details 詳細情報について
-
- CRID
- 1390845713085252096
-
- NII Article ID
- 130007687394
-
- ISSN
- 21897824
- 09168443
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed